Sarah Stutz, BCBA, OT in Morrisville, VT - Behavior Analyst

Sarah Stutz, BCBA, OT is a Behavior Analyst based in Morrisville, Vermont. Sarah Stutz is licensed to practice in Vermont (license number 1-17-28365) and her current practice location is 1040 Frazier Rd, Morrisville, Vermont. She can be reached at her office (for appointments etc.) via phone at (802) 371-9758.

NPI number for Sarah Stutz is 1851174486 and her current mailing address is 1040 Frazier Rd, Morrisville, Vermont. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1851174486.

Contact Information

	Sarah Stutz, BCBA, OT
	1040 Frazier Rd, Morrisville, VT 05661-8566
	(802) 371-9758
	Not Available

Healthcare Provider's Profile

Full Name	Sarah Stutz
Gender	Female
Speciality	Behavior Analyst
Location	1040 Frazier Rd, Morrisville, Vermont
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1851174486
Provider Enumeration Date: 08/16/2023
Last Update Date: 08/16/2023

Medical Identifiers

Medical identifiers for Sarah Stutz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1851174486	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	072.0000468 (Vermont)	Secondary
103K00000X	Behavior Analyst	1-17-28365 (Vermont)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sarah Stutz is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sarah Stutz, BCBA, OT 1040 Frazier Rd, Morrisville, VT 05661-8566 Ph: (802) 371-9758	Sarah Stutz, BCBA, OT 1040 Frazier Rd, Morrisville, VT 05661-8566 Ph: (802) 371-9758

News Archive

Harbor BioSciences announces presentation of new data from Apoptone Phase I/IIa trial at ASCO Annual Meeting

Harbor BioSciences, Inc. today announced that new data from the Phase I/IIa clinical trial of the company's lead drug candidate Apoptone®, its anticancer drug candidate being developed for prostate cancer, will be presented as part of the Scientific Program in a General Poster Session at the American Society of Clinical Oncology (ASCO) Annual Meeting.

BUPA calls for better measurement of healthcare outcomes

Dr Andrew Vallance-Owen, BUPA's medical director will call for improved measurement of the success of surgery across UK healthcare when he speaks at the Health Service Journal (HSJ) conference later today.

Sticky DNA webs may cause tissue damage associated with severe COVID-19 infections

Sticky webs of DNA released from immune cells known as neutrophils may cause much of the tissue damage associated with severe COVID-19 infections, according to two new studies published September 14 in the Journal of Experimental Medicine.

Alternative technique for lumbar fusion with autologous bone plugs

The method presented in this book is a minimally invasive operative technique that applies autologous bone plugs with unilateral oblique posterior intervertebral body fusion instead of foreign body fixation. It is a revolutionary technique for a lumbar fusion operation that uses material from the individual patient and therefore has no risk of rejection.

Sarah Stutz, BCBA, OT - in Morrisville, VT